Search results
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 3 days agoShares of Novavax which makes a Covid-19 vaccine, were up 6.3%. Even vaccine stalwarts like GSK and...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 3 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Arizona researcher publishes study on COVID-19 vaccine and tinnitus
ABC 15 Phoenix· 24 hours agoA newly published scientific study about the COVID-19 vaccine found people with certain preexisting medical conditions were more likely to report ringing ...
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 4 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 ...
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever
The Motley Fool via AOL· 16 hours agoThe company struck gold with its decision to enter the COVID-19 vaccine market. Beyond the stratospheric sales Pfizer was able to generate ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
KFGO· 1 day agoBy Michael Erman (Reuters) - Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research report issued on Wednesday ...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 3 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 4 days agoVaccine manufacturers Novavax and Pfizer said via email they planned to assess their accessibility...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 2 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...